New Zealand approves use of psilocybin for depression treatment

The country’s medicines regulator has approved its first psychiatrist to prescribe psilocybin for treatment-resistant depression outside of clinical trials, providing a new option for patients who have exhausted conventional therapies.

Continue reading...